Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Parkinson's Disease

Free Subscription Articles published in Brain Res Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

March 2010
1. RUSSELL JA , Ciucci MR, Connor NP, Schallert T, et al
   Targeted exercise therapy for voice and swallow in persons with Parkinson's disease.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. BUKHATWA S , Zeng BY, Rose S, Jenner P, et al
   A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. KHAN MM , Ahmad A, Ishrat T, Badruzzaman M, et al
   Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. WANG Y , Zhang QJ, Liu J, Ali U, et al
   Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
5. KATAGIRI N , Chida S, Abe K, Nojima H, et al
   Preventative effects of 1,3-dimethyl- and 1,3-dimethyl-N-propargyl-1,2,3,4-tetrahydroisoquinoline on MPTP-induced Parkinson's disease-like symptoms in mice.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. EZZATI A , Khadjevand F, Zandevakili A, Abbassian A, et al
   Higher level motion detection deficit in Parkinson's disease.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ROCHESTER L , Baker K, Hetherington V, Jones D, et al
   Evidence for motor learning in Parkinson's disease: Acquisition, automaticity and retention of cued gait performance after training with external rhythmical cues.
   Brain Res. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
8. CASTEELS C , Lauwers E, Baitar A, Bormans G, et al
   In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
   Brain Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. LIDIA C , Marie-Therese A, Eleonora Z, Cinzia C, et al
   Multiple Neurogenetic and Neurorescue Effects of Human Mesenchymal Stem Cell After Transplantation in an Experimental Model of Parkinson's Disease.
   Brain Res. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. PEREZ-ALCAZAR M , Nicolas MJ, Valencia M, Alegre M, et al
    Cortical oscillations scan using chirp-evoked potentials in 6-hydroxydopamine rat model of Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. TAJIRI N , Yasuhara T, Shingo T, Kondo A, et al
    Exercise exerts neuroprotective effects on Parkinson's disease model of rats.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. WANG Y , Zhang QJ, Liu J, Ali U, et al
    Noradrenergic lesion of the locus coeruleus increases apoporphine-induced circling behaviour and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
13. HAMAUE N , Ogata A, Terado M, Tsuchida S, et al
    Entacapone, a catechol-O-methyltransferase inhibitor, improves the motor activity and dopamine content of basal ganglia in a rat model of Parkinson's disease induced by Japanese encephalitis virus.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. LIU P , Wang X, Gao N, Zhu H, et al
    G-protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KIM ST , Son HJ, Choi JH, Ji IJ, et al
    Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
16. KAUR D , Rajagopalan S, Andersen JK
    Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. YU L , Hu F, Zou X, Jiang Y, et al
    LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
18. VLAMINGS R , Visser-Vandewalle V, Kozan R, Kaplan S, et al
    Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. STEGEMOLLER EL , Simuni T, Mackinnon C
    The effects of parkinson's disease and age on syncopated finger movements.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
20. CHENG B , Yang X, An L, Gao B, et al
    Ketogenic diet protects dopaminegic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in rat model of Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles   
    
    
    April 2009
21. ANDEREGGEN L , Meyer M, Guzman R, Ducray AD, et al
    Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. YIN GN , Lee HW, Cho JY, Suk K, et al
    Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Brain Res. 2009;1265:158-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
23. PANKONIN MS , Sohi J, Kamholz J, Loeb JA, et al
    Differential distribution of neuregulin in human brain and spinal fluid.
    Brain Res. 2009;1258:1-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
24. DECAMP E , Schneider JS
    Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. JONIEC I , Ciesielska A, Kurkowska-Jastrzebska I, Przybylkowski A, et al
    Age- and sex- differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. GALE JT , Shields DC, Jain FA, Amirnovin R, et al
    Subthalamic nucleus discharge patterns during movement in the normal monkey and Parkinsonian patient.
    Brain Res. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
27. HABIG K , Walter M, Stappert H, Riess O, et al
    Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA - A key player in the pathogenesis of Parkinson's disease.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. GU S , Huang H, Bi J, Yao Y, et al
    Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. SADO M , Yamasaki Y, Iwanaga T, Onaka Y, et al
    Protective effect against Parkinson's disease-related insults through the activation of XBP1.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. KADOTA T , Shingo T, Yasuhara T, Tajiri N, et al
    Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. YING R , Liang HL, Whelan HT, Eells JT, et al
    Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
    Brain Res. 2008;1243:167-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
32. DING H , Wang F, Ding X, Song X, et al
    Association study of semaphorin 5A with risk of Parkinson's disease in a Chinese Han population.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
33. MORRIS JK , Zhang H, Gupte AA, Bomhoff GL, et al
    Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
34. KEITZ M , Koerts J, Kortekaas R, Renken R, et al
    Prefrontal cortex and striatal activation by feedback in Parkinson's disease.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MAZZOCCHIO R , Gelli F, Del Santo F, Popa T, et al
    Effects of posture-related changes in motor cortical output on central oscillatory activity of pathological origin in humans.
    Brain Res. 2008;1223:65-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
36. RUFFOLI R , Giambelluca MA, Scavuzzo MC, Pasquali L, et al
    MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss.
    Brain Res. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
37. KAYA AH , Vlamings R, Tan S, Lim LW, et al
    Increased electrical and metabolic activity in the dorsal raphe nucleus of Parkinsonian rats.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. GELLEIN K , Syversen T, Steinnes E, Nilsen TI, et al
    Trace elements in serum from patients with Parkinson's disease - a prospective case-control study The Nord-Trondelag Health Study (HUNT).
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
39. JENSEN P , Pedersen EG, Zimmer J, Widmer HR, et al
    Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. WRIGHT AK , Miller C, Williams M, Arbuthnott G, et al
    Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. WILLIS GL
    Intraocular microinjections repair experimental Parkinson's disease.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BICK RJ , Poindexter BJ, Kott MM, Liang YA, et al
    Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
43. BRODY KM , Taylor JM, Wilson GR, Delatycki MB, et al
    Regional and cellular localisation of Parkin co-regulated gene in developing and adult mouse brain.
    Brain Res. 2008;1201:177-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. VALVERDE G DE ANDRADE D , Madureira de Oliveria D, Barreto G, Bertolino LA, et al
    Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells.
    Brain Res. 2008;1198:188-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. OYAGI A , Oida Y, Hara H, Izuta H, et al
    Protective effects of SUN N8075, a novel agent with antioxidant properties, in in vitro and in vivo models of Parkinson's disease.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
46. KONG XY , Cai Z, Pan L, Zhang L, et al
    Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. SINGH S , Singh K, Patel S, Patel DK, et al
    Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. KAARIAINEN TM , Piltonen M, Ossola B, Kekki H, et al
    Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. NEHRU B , Verma R, Khanna P, Sharma SK, et al
    Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
50. HASHIMOTO T , Nishi K, Nagasao J, Tsuji S, et al
    Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP(+)) toxicity in dopaminergic neurons.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. AGARI T , Yasuhara T, Matsui T, Kuramoto S, et al
    Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: Behavioral and histological analyses.
    Brain Res. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. AGUIAR LM , Macedo DS, Vasconcelos SM, Oliveira AA, et al
    CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats.
    Brain Res. 2008;1191:192-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2007
53. CHUNG WG , Miranda CL, Maier CS
    Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells.
    Brain Res. 2007;1176:133-42.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: